By the clinical team at Next Step Psychiatry • Lilburn, GA
The GLP-1 Revolution Meets Mental Health
GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have transformed weight management. But as millions of people now take these medications, a pressing question has emerged: how do they affect mental health? The answer is more nuanced—and more hopeful—than headlines suggest.
At Next Step Psychiatry, we’re seeing more patients who are either considering or already taking GLP-1 medications. Here’s what the current research tells us.
The Surprising Benefits: GLP-1s May Improve Depression
Multiple large studies published in 2025–2026 have found that people taking GLP-1 medications have lower rates of depression and anxiety compared to those not on these drugs. A major study of over 2.4 million patients found that GLP-1 users had a 42% lower risk of worsening mental health. Another study found reductions in suicidal ideation among patients taking semaglutide.
Why would a weight loss drug help with depression? GLP-1 receptors exist throughout the brain, including regions involved in mood regulation, reward processing, and stress response. These medications may have direct neurological effects beyond weight loss. Additionally, the confidence and physical improvements from weight loss can significantly boost mood and reduce social anxiety.
Concerns and Side Effects to Monitor
Not everyone’s experience is positive. Some patients report increased anxiety, mood swings, or low mood after starting GLP-1 medications. The rapid body changes, altered relationship with food, and gastrointestinal side effects can be psychologically challenging. For people with a history of eating disorders, GLP-1 medications require careful psychiatric monitoring.
There have also been reports of suicidal thoughts in a small number of patients, though large-scale data suggests these are rare and may not be directly caused by the medication. Regulatory agencies continue to monitor this closely.
| Finding | Study Size | Key Result |
|---|---|---|
| Depression risk reduction | 2.4 million patients | 42% lower risk of worsening mental health |
| Suicidal ideation | Large-scale review | No increased risk; possible reduction |
| Anxiety symptoms | Multiple studies | Generally improved with weight loss |
| Eating disorder risk | Case reports | Requires monitoring in at-risk patients |
GLP-1 Medications and Psychiatric Drug Interactions
GLP-1 medications slow gastric emptying, which can affect how your body absorbs oral psychiatric medications. This means the timing and effectiveness of antidepressants, mood stabilizers, and anti-anxiety medications may be altered. If you’re starting a GLP-1 medication while on psychiatric meds, your psychiatrist should know so they can monitor medication levels and adjust dosing if needed.
Lithium levels, in particular, should be monitored closely as changes in absorption can push levels into the toxic range.
Our Approach at Next Step Psychiatry
We offer medical weight loss services at Next Step Psychiatry, which means we can coordinate your weight management and psychiatric care under one roof. This is a significant advantage—your psychiatrist and weight loss provider are communicating directly about your medications, mood, and progress.
If you’re considering GLP-1 medications and have a mental health condition, scheduling a comprehensive evaluation with us ensures you’re monitored by providers who understand both sides of the equation.
Related Articles
Ready to Take the Next Step?
Our board-certified psychiatrists are here to help. We accept most major insurance plans including Medicare, Medicaid, Aetna, Cigna, Blue Cross Blue Shield, and United Healthcare.
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. If you or someone you know is in crisis, call 911 or the 988 Suicide & Crisis Lifeline.